Carcinoid syndrome

Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil
Carcinoid syndrome ( Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
12 Oct 2016

Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry

Dr Simon Chowdhury - Guy's Hospital, London, UK
Monitoring patterns of care in mCRPC patients with the help of the Cancer Registry ( Dr Simon Chowdhury - Guy's Hospital, London, UK )
10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair
Highlights of ESMO 2016 ( Dr Andrés Cervantes - ESMO 2016 Scientific Chair )
10 Oct 2016

Adjuvant sunitinib for renal cell carcinoma

Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
Adjuvant sunitinib for renal cell carcinoma ( Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France )
10 Oct 2016

Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer

Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer ( Dr Alain Ravaud - Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France )
10 Oct 2016

Custirsen shows no survival benefit in metastatic prostate cancer

Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France
Custirsen shows no survival benefit in metastatic prostate cancer ( Prof Karim Fizazi - Institut Gustave Roussy, Villejuif, France )
10 Oct 2016

Cabozantinib over sunitinib for metastatic renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
Cabozantinib over sunitinib for metastatic renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
10 Oct 2016

Promising results in metastatic bladder cancer using immunotherapy

Dr Matthew Galsky - Mount Sinai, New York, USA
Promising results in metastatic bladder cancer using immunotherapy ( Dr Matthew Galsky - Mount Sinai, New York, USA )
10 Oct 2016

Negative trial results of custirsen for metastatic prostate cancer

Prof Karim Fizazi - Cancer Medicine at the Institut Gustave Roussy, Villejuif, France
Negative trial results of custirsen for metastatic prostate cancer ( Prof Karim Fizazi - Cancer Medicine at the Institut Gustave Roussy, Villejuif, France )
10 Oct 2016

Cabozantinib improves PFS in metastatic renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA
Cabozantinib improves PFS in metastatic renal cell carcinoma ( Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA )
10 Oct 2016

Firstline pembrolizumab for metastatic urothelial cancer

Dr Arjun Balar - NYU Langone Medical Center, New York, USA
Firstline pembrolizumab for metastatic urothelial cancer ( Dr Arjun Balar - NYU Langone Medical Center, New York, USA )
9 Oct 2016

miRNA screening for germ cell tumours

Dr Matthew Murray - University of Cambridge, Cambridge, UK
miRNA screening for germ cell tumours ( Dr Matthew Murray - University of Cambridge, Cambridge, UK )
5 Oct 2016